A citation-based method for searching scientific literature

Yan Xing, Yulia Bronstein, Merrick I Ross, Robert L Askew, Jeffrey E Lee, Jeffrey E Gershenwald, Richard Royal, Janice N Cormier. J Natl Cancer Inst 2011
Times Cited: 160







List of co-cited articles
703 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Final version of 2009 AJCC melanoma staging and classification.
Charles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, John F Thompson, Michael B Atkins, David R Byrd, Antonio C Buzaid, Alistair J Cochran, Daniel G Coit, Shouluan Ding,[...]. J Clin Oncol 2009
23

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Mark B Faries, John F Thompson, Alistair J Cochran, Robert H Andtbacka, Nicola Mozzillo, Jonathan S Zager, Tiina Jahkola, Tawnya L Bowles, Alessandro Testori, Peter D Beitsch,[...]. N Engl J Med 2017
570
21

Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.
Claus Garbe, Andrena Paul, Hanna Kohler-Späth, Ulf Ellwanger, Waltraud Stroebel, Monika Schwarz, Bettina Schlagenhauff, Friedegund Meier, Birgit Schittek, Hans-Juergen Blaheta,[...]. J Clin Oncol 2003
184
18

Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.
Emanuela Romano, Michael Scordo, Stephen W Dusza, Daniel G Coit, Paul B Chapman. J Clin Oncol 2010
141
18

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harold J Hoekstra, Constantine P Karakousis, Christopher A Puleo, Brendon J Coventry,[...]. N Engl J Med 2014
774
18

Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.
Sebastian Podlipnik, Cristina Carrera, Marcelo Sánchez, Pedro Arguis, Maria L Olondo, Ramon Vilana, Ramon Rull, Sergi Vidal-Sicart, Antonio Vilalta, Carles Conill,[...]. J Am Acad Dermatol 2016
34
44

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, Werner Hohenberger, Norbert Brockmeyer, Carola Berking, Cord Sunderkötter, Martin Kaatz, Klaus-Werner Schulte, Percy Lehmann,[...]. Lancet Oncol 2016
326
15

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
14

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
13

Positron emission tomography in the follow-up of cutaneous malignant melanoma patients: a systematic review.
Maria Danielsen, Liselotte Højgaard, Andreas Kjær, Barbara Mb Fischer. Am J Nucl Med Mol Imaging 2013
36
36

Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Michael O Meyers, Jen Jen Yeh, Jill Frank, Patricia Long, Allison M Deal, Keith D Amos, David W Ollila. Ann Surg Oncol 2009
51
25

Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Justin J Baker, Michael O Meyers, Jill Frank, Keith D Amos, Karyn B Stitzenberg, David W Ollila. Am J Surg 2014
23
56

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
C M Balch, S J Soong, J E Gershenwald, J F Thompson, D S Reintgen, N Cascinelli, M Urist, K M McMasters, M I Ross, J M Kirkwood,[...]. J Clin Oncol 2001
12

Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis.
Marie-Lise Bafounta, Alain Beauchet, Sophie Chagnon, Philippe Saiag. Lancet Oncol 2004
83
14

Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis.
Angel M Rodriguez Rivera, Haytham Alabbas, Aliya Ramjaun, Ari-Nareg Meguerditchian. Surg Oncol 2014
27
44

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Jeffrey Weber, Mario Mandala, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas,[...]. N Engl J Med 2017
975
12

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, Vernon K Sondak, Georgina V Long, Merrick I Ross, Alexander J Lazar, Mark B Faries, John M Kirkwood, Grant A McArthur,[...]. CA Cancer J Clin 2017
839
12

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
11

Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma.
I Koskivuo, J Kemppainen, S Giordano, M Seppänen, E Veräjänkorva, P Vihinen, H Minn. Acta Oncol 2016
17
64

Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Michael J Reinhardt, Alexius Y Joe, Ursula Jaeger, Andrea Huber, Alexander Matthies, Jan Bucerius, Roland Roedel, Holger Strunk, Thomas Bieber, Hans-Juergen Biersack,[...]. J Clin Oncol 2006
181
10

Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
Natasha M Rueth, Yan Xing, Yi-Ju Chiang, Kate D Cromwell, Merrick I Ross, Jeffrey E Lee, Jeffrey E Gershenwald, Richard E Royal, Janice N Cormier. Ann Surg 2014
29
34

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015
10

Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.
Molly Yancovitz, Nika Finelt, Melanie A Warycha, Paul J Christos, Madhu Mazumdar, Richard L Shapiro, Anna C Pavlick, Iman Osman, David Polsky, Russell S Berman. Cancer 2007
61
16

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
Georgina V Long, Axel Hauschild, Mario Santinami, Victoria Atkinson, Mario Mandalà, Vanna Chiarion-Sileni, James Larkin, Marta Nyakas, Caroline Dutriaux, Andrew Haydon,[...]. N Engl J Med 2017
641
10

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Alexander M M Eggermont, Christian U Blank, Mario Mandala, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S Carlino,[...]. N Engl J Med 2018
739
10

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Annette Pflugfelder, Corinna Kochs, Andreas Blum, Marcus Capellaro, Christina Czeschik, Therese Dettenborn, Dorothee Dill, Edgar Dippel, Thomas Eigentler, Petra Feyer,[...]. J Dtsch Dermatol Ges 2013
159
9

F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
Milly A Schröer-Günther, Robert F Wolff, Marie E Westwood, Fülöp J Scheibler, Christoph Schürmann, Brigitta G Baumert, Stefan Sauerland, Jos Kleijnen. Syst Rev 2012
24
37

Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Bruno Krug, Ralph Crott, Max Lonneux, Jean-François Baurain, Anne-Sophie Pirson, Thierry Vander Borght. Radiology 2008
84
10

Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, Andrea Forschner, Friedegund Meier, Claus Garbe. Melanoma Res 2010
31
29

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
R Dummer, A Hauschild, N Lindenblatt, G Pentheroudakis, U Keilholz. Ann Oncol 2015
236
9

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
9

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Caroline Robert, Luc Thomas, Igor Bondarenko, Steven O'Day, Jeffrey Weber, Claus Garbe, Celeste Lebbe, Jean-François Baurain, Alessandro Testori, Jean-Jacques Grob,[...]. N Engl J Med 2011
9


Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma.
Roberto A Leon-Ferre, Lisa A Kottschade, Matthew S Block, Robert R McWilliams, Roxana S Dronca, Edward T Creagan, Jacob B Allred, Val J Lowe, Svetomir N Markovic. Melanoma Res 2017
15
60

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.
J Lewin, L Sayers, D Kee, I Walpole, A Sanelli, L Te Marvelde, A Herschtal, J Spillane, D Gyorki, D Speakman,[...]. Ann Oncol 2018
21
42

Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.
Jacqueline Dinnes, Lavinia Ferrante di Ruffano, Yemisi Takwoingi, Seau Tak Cheung, Paul Nathan, Rubeta N Matin, Naomi Chuchu, Sue Ann Chan, Alana Durack, Susan E Bayliss,[...]. Cochrane Database Syst Rev 2019
19
47

PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging.
Yulia Bronstein, Chaan S Ng, Eric Rohren, Merrick I Ross, Jeffrey E Lee, Janice Cormier, Valen E Johnson, Wen-Jen Hwu. AJR Am J Roentgenol 2012
29
27

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.
James Larkin, Paolo A Ascierto, Brigitte Dréno, Victoria Atkinson, Gabriella Liszkay, Michele Maio, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas,[...]. N Engl J Med 2014
8

Sentinel-node biopsy or nodal observation in melanoma.
Donald L Morton, John F Thompson, Alistair J Cochran, Nicola Mozzillo, Robert Elashoff, Richard Essner, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra, Constantine P Karakousis,[...]. N Engl J Med 2006
8

Review of diagnostic imaging modalities for the surveillance of melanoma patients.
Yan Xing, Kate D Cromwell, Janice N Cormier. Dermatol Res Pract 2012
22
36

Improved overall survival in melanoma with combined dabrafenib and trametinib.
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier,[...]. N Engl J Med 2015
8

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
8

Baseline staging in cutaneous malignant melanoma.
J Hafner, M Hess Schmid, W Kempf, G Burg, W Künzi, C Meuli-Simmen, P Neff, V Meyer, D Mihic, E Garzoli,[...]. Br J Dermatol 2004
65
12

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria.
Jedd D Wolchok, Axel Hoos, Steven O'Day, Jeffrey S Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol,[...]. Clin Cancer Res 2009
8

Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
Thomas A Aloia, Jeffrey E Gershenwald, Robert H Andtbacka, Marcella M Johnson, Christopher W Schacherer, Chaan S Ng, Janice N Cormier, Jeffrey E Lee, Merrick I Ross, Paul F Mansfield. J Clin Oncol 2006
60
13

Revised U.K. guidelines for the management of cutaneous melanoma 2010.
J R Marsden, J A Newton-Bishop, L Burrows, M Cook, P G Corrie, N H Cox, M E Gore, P Lorigan, R MacKie, P Nathan,[...]. Br J Dermatol 2010
229
8

Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
F Crippa, M Leutner, F Belli, F Gallino, M Greco, S Pilotti, N Cascinelli, E Bombardieri. J Nucl Med 2000
133
7

Improved survival with MEK inhibition in BRAF-mutated melanoma.
Keith T Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev V Demidov, Jessica C Hassel, Piotr Rutkowski, Peter Mohr,[...]. N Engl J Med 2012
7

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Christina Pfannenberg, Philip Aschoff, Sandra Schanz, Susanne M Eschmann, Christian Plathow, Thomas K Eigentler, Claus Garbe, Klaus Brechtel, Reinhard Vonthein, Roland Bares,[...]. Eur J Cancer 2007
133
7

Imaging in cutaneous melanoma.
Ivan A Ho Shon, David K V Chung, Robyn P M Saw, John F Thompson. Nucl Med Commun 2008
44
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.